Global Health and Longevity: Challenges and Opportunities | David Barzilai
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →About this video
Creator description · original language
Dr. David Barzilai, MD, PhD, is a globally recognized longevity physician and CEO of Barzilai Longevity Consulting, where he provides advanced, evidence-based strategies to extend and optimize healthspan. A founding faculty member and Trustee of the Geneva College of Longevity Science, Dr. Barzilai is a lecturer at Harvard Medical School and a Diplomate of the American Board of Lifestyle Medicine (DipABLM). Through agingdoc.com, he provides personalized longevity consultations that translate cutting-edge research into practical, high-impact interventions for individuals, businesses, and organizations.
At the 6th #TimepieLongevityForum, Dr. Barzilai outlined the global economic impact of delaying disease and disability—emphasizing that even a one-year delay could yield $38 trillion worldwide—and underscored that targeting the hallmarks of aging represents the most powerful path forward. He urged regulators to formally recognize aging as a treatable condition to unlock innovation in therapeutic development.
Timepie Longevity Forum is China’s premier longevity innovation summit, uniting leading scientists, clinicians, and translational innovators to advance healthy life extension and accelerate breakthroughs in aging biology.
Learn more about Timepie Longevity Forum:
https://www.timepielongevityforum.com
To connect with Dr. Barzilai for keynote speaking, advisory roles, or consulting in longevity medicine, visit: linkedin.com/in/agingdoc
TimePie · 25 min · Source published: 2025-12-16
Added to Harbor: 10/22/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.